Respiratory Endotherapy Devices

Respiratory Endotherapy Devices

A respiratory endotherapy involves the assessment of trachea, bronchi and part of the lungs and mainly used for collecting samples for clinical and anatomic pathology lab testing. It is very effective procedure in the diagnosis of tumors and infectious diseases. As the prevalence of respiratory disorders, including asthma, COPD, bronchitis, lung cancer etc. is increasing continuously, which results in a significant rise in the demand of respiratory devices, including respiratory endotherapy devices. The market for Respiratory Endotherapy Devices is mainly driven by increasing endotherapy procedures, the increasing prevalence of respiratory disorders, technological advancement in endotherapy equipment, and rising awareness about the benefits of early diagnosis. For instance, as per the US Food & Drug Administration (FDA), more than 500,000 bronchoscopy are performed every year in US.

The Respiratory Endotherapy Devices market was valued at USD 1,521.38 million in 2022 and is expected to grow at a CAGR of around 6.5% from 2023-2030.

• Based on the device, the market is segmented into diagnostic devices and therapeutic devices. The therapeutic devices category dominated the market in 2022 and hold a share of 60.15% of the total market. Respiratory endotherapy is recommended when there is a need of aspirating thick section that are causing atelectasis of lungs, to remove foreign bodies from the lungs and reduce or remove tumors in the trachea or bronchi. Rising cases of pulmonary disorders, and launch of technologically advanced bronchoscopes are driving the market of therapeutic devices segment.
• On the basis of end-users, the market is categorized into Hospitals, diagnostic centers, and ambulatory surgical centers. Among these, the hospital’s category held a significant share of the market in 2022. This is mainly due to the high volume of respiratory endotherapy procedures performed in hospitals, as well as the availability of advanced medical equipment and expertise in this setting. Further, increasing demand for minimally invasive procedures and the growing availability of advanced medical equipment and technologies are also contributing to the growth of the market
• For a better understanding of the market adoption of the industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Rest of World. North America held dominating share of the Respiratory Endotherapy Devices market in 2022. The presence of well-established healthcare infrastructure, along with the increasing healthcare expenditure in the countries is the major attributing factor for the market growth in North America.
• Some of the major players operating in the market include Fujifilm Holdings Corporation, Medtronic, Johnson & Johnson, Smith & Nephew Plc., Stryker corporation, Olympus, Hoya corporation, Steris Healthcare, Conmed, and Boston corporation among others.